150 related articles for article (PubMed ID: 8474535)
1. Different effects of 1-methyl-4-phenyl-pyridinium (MPP+) on monoamine oxidase of dopaminergic terminals in caudate nucleus slices from pigmented and from albino rabbits.
Lupp A; Lücking CH; Hedler L; Feuerstein TJ
Naunyn Schmiedebergs Arch Pharmacol; 1993 Feb; 347(2):141-6. PubMed ID: 8474535
[TBL] [Abstract][Full Text] [Related]
2. An in vitro model of 1-methyl-4-phenyl-pyridinium (MPP+) toxicity: incubation of rabbit caudate nucleus slices with MPP+ followed by biochemical and functional analysis.
Feuerstein TJ; Hedler L; Jackisch R; Hertting G
Br J Pharmacol; 1988 Oct; 95(2):449-58. PubMed ID: 3265882
[TBL] [Abstract][Full Text] [Related]
3. Different effects of serotonin (5-HT) uptake blockers in caudate nucleus and hippocampus of the rabbit: role of monoamine oxidase in dopaminergic terminals.
Lupp A; Bär KI; Lücking CH; Feuerstein TJ
Psychopharmacology (Berl); 1992; 106(1):118-26. PubMed ID: 1738788
[TBL] [Abstract][Full Text] [Related]
4. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine.
Feuerstein TJ; Hertting G; Lupp A; Neufang B
Br J Pharmacol; 1986 Jul; 88(3):677-84. PubMed ID: 3742155
[TBL] [Abstract][Full Text] [Related]
5. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
Azzaro AJ; King J; Kotzuk J; Schoepp DD; Frost J; Schochet S
J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
[TBL] [Abstract][Full Text] [Related]
6. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
[TBL] [Abstract][Full Text] [Related]
7. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
9. Deprenyl alters behavior and caudate dopamine through an amphetamine-like action.
Okuda C; Segal DS; Kuczenski R
Pharmacol Biochem Behav; 1992 Dec; 43(4):1075-80. PubMed ID: 1475291
[TBL] [Abstract][Full Text] [Related]
10. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
Riederer P; Youdim MB
J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
[TBL] [Abstract][Full Text] [Related]
12. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Itzhak Y; Mash D; Zhang SH; Stein I
Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
[TBL] [Abstract][Full Text] [Related]
13. The effect of N-methyl-norsalsolinol on monoamine oxidase of the rat caudate nucleus in vitro.
Moser A; Scholz J; Bamberg H; Böhme V
Neurochem Int; 1996 Jan; 28(1):109-12. PubMed ID: 8746770
[TBL] [Abstract][Full Text] [Related]
14. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Mytilineou C; Cohen G
J Neurochem; 1985 Dec; 45(6):1951-3. PubMed ID: 3932598
[TBL] [Abstract][Full Text] [Related]
15. Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.
Wu RM; Chen RC; Chiueh CC
Ann N Y Acad Sci; 2000; 899():255-61. PubMed ID: 10863544
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine.
Mihatsch W; Russ H; Przuntek H
J Neural Transm; 1988; 71(3):177-88. PubMed ID: 3128644
[TBL] [Abstract][Full Text] [Related]
18. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition.
Le W; Jankovic J; Xie W; Kong R; Appel SH
Neurosci Lett; 1997 Mar; 224(3):197-200. PubMed ID: 9131670
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
20. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE
Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
